Inovio Pharmaceuticals is trading at $1.19, up 5.31%, with no clear company-specific announcement explaining the move on October 7, 2026.

  • Recent coverage points to the October 30 FDA decision date for INO-3107, but that is not new today.
  • The gain contrasts with XBI down 2.50% and a generally weaker market; neither clearly explains the move.
  • Reported volume was 2.01 million versus a 2.56 million daily average, though it may not reflect the live session.